This session aims to enhance the clinician’s knowledge of psychopharmacology, including the use of pharmacogenomic testing to guide practice decisions. The presentation includes a special focus on the role of sleep and its relationship to a symptom course, prediction of treatment response, and risk for relapse.

Contact hours available until 3/17/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures: There are no disclosures to declare.

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

Learning Outcome:
After attending this session, the learner will be able to identify current trends to psychopharmacologic treatment of older adults, nased on current standards of practice and advancements in the knowledge of clinical psychopharmcology with a special focus on sleep and risks for medical/psychiatric comorbidities.